BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9987713)

  • 1. Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found.
    Mercier G; Turpin JC; Lucotte G
    J Neurol; 1999 Jan; 246(1):45-7. PubMed ID: 9987713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients.
    Lin JJ; Yueh KC; Chang DC; Chang CY; Yeh YH; Lin SZ
    J Neurol Sci; 2003 May; 209(1-2):87-92. PubMed ID: 12686408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine transporter gene and Parkinson's disease in a Chinese population.
    Leighton PW; Le Couteur DG; Pang CC; McCann SJ; Chan D; Law LK; Kay R; Pond SM; Woo J
    Neurology; 1997 Dec; 49(6):1577-9. PubMed ID: 9409349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between dopamine transporter gene polymorphism and Parkinson's disease].
    Zhang L; Shao M; Xu Q; Dong X; Yang J; Li Y; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):431-4. PubMed ID: 11774209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the dopamine transporter gene with Parkinson's disease in Korean patients.
    Kim JW; Kim DH; Kim SH; Cha JK
    J Korean Med Sci; 2000 Aug; 15(4):449-51. PubMed ID: 10983695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease.
    Higuchi S; Muramatsu T; Arai H; Hayashida M; Sasaki H; Trojanowski JQ
    J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):107-13. PubMed ID: 9620058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):346-8. PubMed ID: 11798784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serotonin transporter gene and Parkinson's disease.
    McCann SJ; McManus ME; Johnson AG; Mellick GD; Le Couteur DG; Pond SM
    Eur Neurol; 2000; 44(2):108-11. PubMed ID: 10965163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
    Le Couteur DG; Leighton PW; McCann SJ; Pond Sm
    Mov Disord; 1997 Sep; 12(5):760-3. PubMed ID: 9380062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.
    Barr CL; Xu C; Kroft J; Feng Y; Wigg K; Zai G; Tannock R; Schachar R; Malone M; Roberts W; Nöthen MM; Grünhage F; Vandenbergh DJ; Uhl G; Sunohara G; King N; Kennedy JL
    Biol Psychiatry; 2001 Feb; 49(4):333-9. PubMed ID: 11239904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence of association between a dopamine transporter gene polymorphism (1215A/G) and Parkinson's disease.
    Kimura M; Matsushita S; Arai H; Takeda A; Higuchi S
    Ann Neurol; 2001 Feb; 49(2):276-7. PubMed ID: 11220753
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of dopamine transporter binding availability by genotype: a preliminary report.
    Jacobsen LK; Staley JK; Zoghbi SS; Seibyl JP; Kosten TR; Innis RB; Gelernter J
    Am J Psychiatry; 2000 Oct; 157(10):1700-3. PubMed ID: 11007732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
    Martinez D; Gelernter J; Abi-Dargham A; van Dyck CH; Kegeles L; Innis RB; Laruelle M
    Neuropsychopharmacology; 2001 May; 24(5):553-60. PubMed ID: 11282255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders.
    Ohara K; Suzuki Y; Ochiai M; Tsukamoto T; Tani K; Ohara K
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):55-65. PubMed ID: 10368856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
    Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of the dopamine and serotonin transporter genetic polymorphisms and methamphetamine abuse in Chinese males.
    Hong CJ; Cheng CY; Shu LR; Yang CY; Tsai SJ
    J Neural Transm (Vienna); 2003 Apr; 110(4):345-51. PubMed ID: 12658362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of the 3' VNTR region of the human dopaminergic function gene DAT1 (human dopamine transporter gene) in the Mongolian population.
    Nakatome M; Honda K; Tun Z; Kato Y; Harihara S; Omoto K; Misawa S; Gerelsaikhan T; Nyamkhishig S; Dashnyam B; Batsuuri J; Wakasugi C
    Hum Biol; 1996 Aug; 68(4):509-15. PubMed ID: 8754257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers.
    Jeong SH; Joo EJ; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):975-83. PubMed ID: 15380858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease.
    Kelada SN; Costa-Mallen P; Checkoway H; Carlson CS; Weller TS; Swanson PD; Franklin GM; Longstreth WT; Afsharinejad Z; Costa LG
    Pharmacogenet Genomics; 2005 Sep; 15(9):659-68. PubMed ID: 16041244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.